Beiersdorf/Senetek collaboration
This article was originally published in The Rose Sheet
Executive Summary
Nivea skin care marketer Beiersdorf and Kinetin technology manufacturer Senetek form research agreement allowing Beiersdorf to conduct laboratory and in vivo evaluations of various skin care compounds owned by Senetek, two firms announce June 25. At the conclusion of each evaluation, Beiersdorf will have opportunity to enter licensing agreements to use the compound in its own products in global markets, while Senetek will maintain the right to license the compounds in markets not tapped by Beiersdorf, companies say. Beiersdorf's research and development programs in skin care are focused on protecting the skin from photodamage and treating skin aging, company adds. Senetek's Kinetin anti-aging technology also is used by Revlon and The Body Shop...
You may also be interested in...
Senetek Expects To License Zeatin Technology In 12 To 18 Months
Healthcare technology company Senetek expects to have a new patented anti-aging compound, Zeatin, ready to license to skin care manufacturers within the next 12 to 18 months, Chairman and CEO Frank Massino said, cautioning the timeframe will be directed by the timing of upcoming pre-clinical and clinical efficacy studies
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.